Cryoport Inc
CYRX7.270USD
-0.060-0.82%
Handelsschluss 08/01, 16:00（ET）Kurse um 15 Minuten verzögert
364.50MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Cryoport Inc Unternehmen
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
Unternehmensinformationen
BörsenkürzelCYRX
Name des UnternehmensCryoport Inc
IPO-datumJul 24, 2015
Gegründet am1990
CEOMr. Jerrell Wilson (Jerry) Shelton
Anzahl der mitarbeiter1090
WertpapierartOrdinary Share
GeschäftsjahresendeJul 24
Addresse112 Westwood Place, Suite 350
StadtBRENTWOOD
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl37027
Telefon19492321900
Websitehttps://www.cryoport.com/
BörsenkürzelCYRX
IPO-datumJul 24, 2015
Gegründet am1990
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
950.92K
+8.56%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
45.86K
+102.52%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
44.90K
+107.03%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
18.43K
+138.85%
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
--
--
Mr. Ram M. Jagannath
Mr. Ram M. Jagannath
Independent Director
Independent Director
--
--
Mr. Scott Eckstein
Mr. Scott Eckstein
Investor Relations
Investor Relations
--
--
Mr. Edward J. Zecchini
Mr. Edward J. Zecchini
Senior Vice President, Chief Digital and Technology Officer
Senior Vice President, Chief Digital and Technology Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
950.92K
+8.56%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
45.86K
+102.52%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
44.90K
+107.03%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
18.43K
+138.85%
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
BioLogistics solutions
18.53M
45.15%
Life Science products
18.18M
44.29%
BioStorage/Bioservices
4.33M
10.56%
Nach RegionUSD
Name
Umsatz
Anteil
Americas
32.20M
78.45%
Europe & Middle East & Africa (EMEA)
5.58M
13.60%
Asia Pacific
3.27M
7.96%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
BioLogistics solutions
18.53M
45.15%
Life Science products
18.18M
44.29%
BioStorage/Bioservices
4.33M
10.56%
Aktionärsstatistik
Aktualisiert: Thu, May 15
Aktualisiert: Thu, May 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Cadian Capital Management LP
9.94%
Morgan Stanley & Co. LLC
9.19%
Brown Capital Management, LLC
8.09%
Millennium Management LLC
6.71%
BlackRock Institutional Trust Company, N.A.
6.49%
Other
59.59%
Aktionäre
Aktionäre
Anteil
Cadian Capital Management LP
9.94%
Morgan Stanley & Co. LLC
9.19%
Brown Capital Management, LLC
8.09%
Millennium Management LLC
6.71%
BlackRock Institutional Trust Company, N.A.
6.49%
Other
59.59%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
37.62%
Investment Advisor/Hedge Fund
24.62%
Hedge Fund
21.59%
Research Firm
10.87%
Individual Investor
3.83%
Pension Fund
2.50%
Private Equity
1.04%
Sovereign Wealth Fund
0.70%
Bank and Trust
0.34%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
391
51.80M
103.33%
-13.32M
2025Q1
409
50.98M
101.73%
-14.79M
2024Q4
407
51.87M
104.93%
-14.28M
2024Q3
422
52.00M
105.24%
-13.61M
2024Q2
423
53.55M
108.72%
-9.95M
2024Q1
437
55.31M
112.51%
-7.56M
2023Q4
468
54.03M
110.37%
-6.18M
2023Q3
482
49.41M
101.04%
-7.52M
2023Q2
492
49.81M
109.19%
-5.40M
2023Q1
500
48.02M
99.15%
-8.43M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Cadian Capital Management LP
4.98M
9.94%
+55.00K
+1.12%
Mar 31, 2025
Morgan Stanley & Co. LLC
4.61M
9.19%
-2.84K
-0.06%
Mar 31, 2025
Brown Capital Management, LLC
4.05M
8.09%
-405.16K
-9.09%
Mar 31, 2025
Millennium Management LLC
3.36M
6.71%
-778.06K
-18.79%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.25M
6.49%
+229.97K
+7.61%
Mar 31, 2025
The Vanguard Group, Inc.
2.75M
5.48%
+13.24K
+0.48%
Mar 31, 2025
Fred Alger Management, LLC
2.53M
5.05%
-34.58K
-1.35%
Mar 31, 2025
Natixis Investment Managers SA
1.70M
3.39%
-15.64K
-0.91%
Mar 31, 2025
DWS Investments UK Limited
1.39M
2.78%
-4.68K
-0.34%
Mar 31, 2025
New York State Common Retirement Fund
1.15M
2.28%
--
--
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: 4 hours ago
Aktualisiert: 4 hours ago
Name
Anteil
Invesco NASDAQ Future Gen 200 ETF
0.56%
Inspire Small/Mid Cap ESG ETF
0.24%
JPMorgan Fundamental Data Science Small Core ETF
0.07%
Avantis US Small Cap Equity ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 Value ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Mehr Anzeigen
Invesco NASDAQ Future Gen 200 ETF
Anteil0.56%
Inspire Small/Mid Cap ESG ETF
Anteil0.24%
JPMorgan Fundamental Data Science Small Core ETF
Anteil0.07%
Avantis US Small Cap Equity ETF
Anteil0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.03%
iShares Russell 2000 Value ETF
Anteil0.02%
Invesco RAFI US 1500 Small-Mid ETF
Anteil0.01%
Schwab U.S. Small-Cap ETF
Anteil0.01%
iShares Russell 2000 Growth ETF
Anteil0.01%
ProShares Hedge Replication ETF
Anteil0.01%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
